Index RUT
P/E -
EPS (ttm) -1.80
Insider Own 6.62%
Shs Outstand 56.35M
Perf Week -3.88%
Market Cap 1.37B
Forward P/E -
EPS next Y -0.62
Insider Trans -3.75%
Shs Float 53.95M
Perf Month -4.49%
Income -100.32M
PEG -
EPS next Q -0.27
Inst Own 94.64%
Short Float 4.93%
Perf Quarter 17.20%
Sales 389.96M
P/S 3.52
EPS this Y 52.76%
Inst Trans -5.29%
Short Ratio 6.54
Perf Half Y 0.65%
Book/sh 4.36
P/B 5.45
EPS next Y 48.06%
ROA -28.55%
Short Interest 2.66M
Perf Year 25.91%
Cash/sh 1.42
P/C 16.76
EPS next 5Y -
ROE -40.26%
52W Range 12.05 - 29.16
Perf YTD 2.52%
Dividend Est. -
P/FCF -
EPS past 5Y -15.39%
ROI -38.63%
52W High -18.60%
Beta 0.94
Dividend TTM -
Quick Ratio 1.77
Sales past 5Y 29.21%
Gross Margin 58.96%
52W Low 96.96%
ATR (14) 1.29
Dividend Ex-Date -
Current Ratio 1.77
EPS Y/Y TTM 37.24%
Oper. Margin -24.58%
RSI (14) 47.55
Volatility 4.84% 5.36%
Employees 1438
Debt/Eq 0.07
Sales Y/Y TTM 22.10%
Profit Margin -25.73%
Recom 1.29
Target Price 29.31
Option/Short Yes / Yes
LT Debt/Eq 0.03
EPS Q/Q 54.18%
Payout -
Rel Volume 0.93
Prev Close 23.76
Sales Surprise 0.51%
EPS Surprise 12.45%
Sales Q/Q 18.97%
Earnings Sep 04 AMC
Avg Volume 406.79K
Price 23.73
SMA20 -3.22%
SMA50 -0.90%
SMA200 2.83%
Trades
Volume 336,810
Change -0.11%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-24 Initiated
Truist
Buy
$35
Jan-17-24 Upgrade
DA Davidson
Neutral → Buy
$30 → $32
Jan-03-24 Initiated
Barclays
Overweight
$29
Apr-12-23 Initiated
Stephens
Overweight
$37
Jan-04-23 Reiterated
Needham
Buy
$35 → $40
Dec-13-22 Upgrade
Citigroup
Neutral → Buy
$40
Dec-09-22 Upgrade
SVB Leerink
Mkt Perform → Outperform
$31 → $34
Oct-13-22 Initiated
DA Davidson
Neutral
$25
Sep-16-22 Initiated
KeyBanc Capital Markets
Overweight
$40
Apr-14-22 Initiated
Guggenheim
Buy
$45
Jan-06-22 Downgrade
SVB Leerink
Outperform → Mkt Perform
$57 → $41
Dec-02-21 Initiated
Jefferies
Buy
$70
Sep-02-21 Reiterated
Needham
Buy
$70 → $81
Aug-27-21 Initiated
Canaccord Genuity
Buy
$81
Jul-13-21 Initiated
JMP Securities
Mkt Outperform
$80
Jun-08-21 Initiated
Berenberg
Buy
$70
Apr-29-21 Resumed
JP Morgan
Overweight
$64
Apr-01-21 Initiated
Robert W. Baird
Outperform
$60
Nov-11-20 Initiated
Stephens
Overweight
$50
Oct-27-20 Initiated
Needham
Buy
$44
Show Previous Ratings
Sep-19-24 06:48AM
Sep-17-24 04:28PM
Sep-05-24 12:39PM
(Thomson Reuters StreetEvents) +6.29%
Sep-04-24 06:00PM
05:15PM
04:15PM
Loading…
04:15PM
(Associated Press Finance)
04:03PM
Sep-03-24 09:03AM
Aug-29-24 09:15AM
06:48AM
Aug-08-24 06:48AM
Aug-05-24 09:00PM
Aug-01-24 06:48AM
Jul-30-24 06:48AM
Jul-19-24 09:55AM
12:00PM
Loading…
Jul-12-24 12:00PM
Jun-10-24 10:26AM
Jun-04-24 09:35AM
May-31-24 11:59AM
(Thomson Reuters StreetEvents) -11.22%
May-30-24 08:54PM
05:30PM
05:15PM
04:08PM
(Associated Press Finance)
04:03PM
May-28-24 06:48AM
May-24-24 09:15AM
May-23-24 04:30PM
May-21-24 04:30PM
May-01-24 06:46AM
Apr-29-24 06:48AM
07:01PM
Loading…
Mar-25-24 07:01PM
Mar-19-24 06:48AM
Mar-17-24 10:22AM
Mar-15-24 06:56AM
(Thomson Reuters StreetEvents)
Mar-14-24 08:55PM
06:00PM
05:25PM
04:22PM
(Associated Press Finance)
04:03PM
Mar-07-24 10:00AM
Feb-27-24 04:05PM
Feb-20-24 06:48AM
Feb-19-24 11:53AM
Feb-05-24 04:05PM
06:54AM
Jan-23-24 06:40AM
Jan-18-24 07:59PM
Jan-16-24 04:05PM
Jan-11-24 06:44AM
Dec-27-23 09:55AM
08:06AM
Dec-11-23 09:55AM
Dec-08-23 08:21AM
Dec-06-23 10:37AM
(Thomson Reuters StreetEvents) +21.22%
Dec-05-23 06:00PM
05:40PM
05:15PM
04:17PM
(Associated Press Finance)
04:03PM
Dec-01-23 06:00AM
Nov-16-23 03:12AM
Nov-08-23 06:00AM
Nov-01-23 09:12AM
06:03AM
Sep-15-23 10:01PM
Sep-14-23 09:39PM
Sep-11-23 12:11PM
Sep-07-23 12:08PM
11:45AM
09:30AM
09:00AM
07:37AM
(Thomson Reuters StreetEvents)
Sep-06-23 05:15PM
04:07PM
04:03PM
Sep-04-23 12:00PM
09:55AM
08:39AM
Aug-31-23 08:40AM
Aug-16-23 12:58PM
Aug-15-23 05:11PM
Aug-14-23 04:03PM
Aug-07-23 06:50PM
Aug-01-23 06:03AM
Jul-20-23 08:40PM
Jul-14-23 04:48PM
Jul-13-23 04:03PM
Jul-11-23 12:00PM
Jun-13-23 06:43AM
May-31-23 06:30PM
05:15PM
04:08PM
04:03PM
May-17-23 04:03PM
May-16-23 04:05PM
May-15-23 05:45PM
May-11-23 05:35PM
May-09-23 05:35PM
May-07-23 08:06AM
May-04-23 08:25AM
Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Linetsky David SVP, Life Sciences Sep 18 '24 Sale 24.09 61 1,469 8,995 Sep 19 05:49 PM Linetsky David SVP, Life Sciences Sep 17 '24 Sale 24.77 36 892 9,056 Sep 19 05:49 PM Linetsky David Member of immediate family of Sep 19 '24 Proposed Sale 24.04 24 577 Sep 19 04:13 PM Linetsky David Member of immediate family of Sep 18 '24 Proposed Sale 24.09 61 1,469 Sep 18 03:51 PM Linetsky David Member of immediate family of Sep 17 '24 Proposed Sale 24.77 36 892 Sep 17 03:38 PM Egbuonu-Davis Lisa Director Sep 12 '24 Sale 23.03 1,400 32,239 18,139 Sep 13 04:06 PM Gandhi Balaji Chief Financial Officer Sep 10 '24 Sale 23.25 3,502 81,422 98,578 Sep 12 06:03 PM Hui Yvonne Principal Accounting Officer Sep 10 '24 Sale 23.25 744 17,298 30,019 Sep 12 06:02 PM Indig Chaim Chief Executive Officer Sep 10 '24 Sale 23.25 5,295 123,110 1,223,736 Sep 12 06:00 PM Linetsky David SVP, Life Sciences Sep 10 '24 Sale 23.25 1,716 39,897 203,318 Sep 12 05:58 PM Linetsky David SVP, Life Sciences Sep 10 '24 Sale 23.25 95 2,209 9,092 Sep 12 05:58 PM Roberts Evan Chief Operating Officer Sep 10 '24 Sale 23.25 3,148 73,192 755,719 Sep 12 05:55 PM VanDuyn Amy Beth SVP, Human Resources Sep 10 '24 Sale 23.25 737 17,135 119,541 Sep 12 05:53 PM Hoffman Allison C General Counsel & Secretary Sep 10 '24 Sale 23.25 2,622 60,962 123,075 Sep 12 05:51 PM Hoffman Allison C General Counsel & Secretary Sep 11 '24 Sale 23.36 2,072 48,402 121,003 Sep 12 05:51 PM Egbuonu-Davis Lisa Director Sep 12 '24 Proposed Sale 23.03 1,400 32,239 Sep 12 02:04 PM Hoffman Allison C Officer Sep 11 '24 Proposed Sale 23.36 2,072 48,402 Sep 11 09:54 AM Indig Chaim Officer Sep 10 '24 Proposed Sale 23.25 5,295 123,110 Sep 10 05:00 PM Roberts Evan Officer Sep 10 '24 Proposed Sale 23.25 3,148 73,192 Sep 10 04:52 PM VanDuyn Amy Beth Officer Sep 10 '24 Proposed Sale 23.25 737 17,135 Sep 10 04:48 PM Linetsky David Member of immediate family of Sep 10 '24 Proposed Sale 23.25 95 2,209 Sep 10 04:48 PM Hoffman Allison C Officer Sep 10 '24 Proposed Sale 23.25 2,622 60,962 Sep 10 04:38 PM Gandhi Balaji Officer Sep 10 '24 Proposed Sale 23.25 3,502 81,422 Sep 10 04:32 PM Linetsky David Officer Sep 10 '24 Proposed Sale 23.25 1,716 39,897 Sep 10 04:28 PM Hui Yvonne Officer Sep 10 '24 Proposed Sale 23.25 744 17,298 Sep 10 04:18 PM Hoffman Allison C General Counsel & Secretary Aug 26 '24 Sale 26.03 14,110 367,241 121,003 Aug 28 04:57 PM Hoffman Allison C Officer Aug 26 '24 Proposed Sale 26.03 14,110 367,244 Aug 26 03:17 PM Indig Chaim Chief Executive Officer Jul 29 '24 Option Exercise 2.03 7 14 1,219,368 Jul 30 05:05 PM Indig Chaim Chief Executive Officer Jul 29 '24 Sale 24.75 7 173 1,219,361 Jul 30 05:05 PM Gunzburg Janet Officer Jul 29 '24 Proposed Sale 24.64 202 4,977 Jul 29 03:36 PM Indig Chaim Officer Jul 29 '24 Proposed Sale 24.75 7 173 Jul 29 11:12 AM Smith Mark Douglas Director Jul 18 '24 Option Exercise 4.71 7,000 32,970 37,653 Jul 22 04:56 PM Smith Mark Douglas Director Jul 18 '24 Sale 25.00 7,000 175,000 30,653 Jul 22 04:56 PM Linetsky David SVP, Life Sciences Jul 16 '24 Sale 23.74 1,820 43,199 202,218 Jul 17 05:31 PM Indig Chaim Chief Executive Officer Jul 16 '24 Sale 23.74 2,644 62,757 1,219,361 Jul 17 05:30 PM Hui Yvonne Principal Accounting Officer Jul 16 '24 Sale 23.74 283 6,717 28,714 Jul 17 05:29 PM Hoffman Allison C General Counsel & Secretary Jul 16 '24 Sale 23.74 800 18,988 135,113 Jul 17 05:28 PM Gandhi Balaji Chief Financial Officer Jul 16 '24 Sale 23.74 783 18,585 96,447 Jul 17 05:27 PM VanDuyn Amy Beth SVP, Human Resources Jul 16 '24 Sale 23.74 374 8,877 118,636 Jul 17 05:26 PM Roberts Evan Chief Operating Officer Jul 16 '24 Sale 23.74 1,669 39,615 753,234 Jul 17 05:24 PM Gunzburg Janet Principal Accounting Officer Jun 21 '24 Sale 20.24 114 2,307 34,820 Jun 24 04:30 PM Linetsky David SVP, Life Sciences Jun 21 '24 Sale 20.24 27 546 6,953 Jun 24 04:29 PM Linetsky David SVP, Life Sciences Jun 20 '24 Sale 19.73 66 1,302 6,980 Jun 21 04:35 PM Linetsky David SVP, Life Sciences Jun 18 '24 Sale 19.20 41 787 7,046 Jun 21 04:35 PM Gunzburg Janet Principal Accounting Officer May 01 '24 Sale 21.00 286 6,006 34,934 May 02 04:22 PM Gunzburg Janet Principal Accounting Officer Apr 18 '24 Sale 22.85 912 20,836 35,220 Apr 19 04:24 PM Linetsky David SVP, Life Sciences Apr 18 '24 Sale 22.85 269 6,146 7,087 Apr 19 04:24 PM VanDuyn Amy Beth SVP, Human Resources Apr 15 '24 Sale 22.86 685 15,657 119,010 Apr 17 04:13 PM Linetsky David SVP, Life Sciences Apr 15 '24 Sale 22.86 2,212 50,561 204,038 Apr 17 04:13 PM Roberts Evan Chief Operating Officer Apr 15 '24 Sale 22.86 2,029 46,378 754,903 Apr 17 04:13 PM Hoffman Allison C General Counsel & Secretary Apr 15 '24 Sale 22.86 1,238 28,297 135,621 Apr 17 04:10 PM Gandhi Balaji Chief Financial Officer Apr 15 '24 Sale 22.86 948 21,669 97,230 Apr 17 04:08 PM Indig Chaim Chief Executive Officer Apr 15 '24 Sale 22.86 3,392 77,532 1,222,005 Apr 17 04:07 PM Gunzburg Janet Principal Accounting Officer Apr 10 '24 Sale 23.10 2,768 63,928 36,132 Apr 12 06:40 PM Hoffman Allison C General Counsel & Secretary Apr 08 '24 Sale 22.62 5,549 125,519 141,485 Apr 10 05:20 PM Hoffman Allison C General Counsel & Secretary Apr 09 '24 Sale 23.42 4,626 108,360 136,859 Apr 10 05:20 PM Gandhi Balaji Chief Financial Officer Apr 08 '24 Sale 22.62 7,778 175,939 98,178 Apr 10 05:19 PM Indig Chaim Chief Executive Officer Apr 08 '24 Sale 22.62 12,043 272,414 1,225,397 Apr 10 05:19 PM VanDuyn Amy Beth SVP, Human Resources Apr 09 '24 Sale 23.43 3,768 88,277 119,695 Apr 10 05:19 PM VanDuyn Amy Beth SVP, Human Resources Apr 08 '24 Sale 22.62 3,354 75,868 123,463 Apr 10 05:19 PM Roberts Evan Chief Operating Officer Apr 09 '24 Option Exercise 2.03 23,330 47,360 756,932 Apr 10 05:18 PM Roberts Evan Chief Operating Officer Apr 08 '24 Sale 22.62 7,178 162,367 733,602 Apr 10 05:18 PM Linetsky David SVP, Life Sciences Apr 08 '24 Sale 22.62 3,914 88,535 206,250 Apr 10 05:18 PM Linetsky David SVP, Life Sciences Apr 08 '24 Sale 22.62 247 5,587 7,356 Apr 10 05:18 PM Gunzburg Janet Principal Accounting Officer Mar 19 '24 Sale 23.27 2,817 65,561 40,609 Apr 10 05:18 PM Gunzburg Janet Principal Accounting Officer Apr 08 '24 Sale 22.62 1,709 38,658 38,900 Apr 10 05:18 PM Gandhi Balaji Chief Financial Officer Mar 25 '24 Sale 23.21 3,504 81,332 94,030 Mar 27 04:06 PM Roberts Evan Chief Operating Officer Mar 21 '24 Sale 23.52 25,962 610,684 728,570 Mar 25 04:16 PM Gunzburg Janet Principal Accounting Officer Mar 20 '24 Sale 23.66 137 3,241 38,949 Mar 21 04:11 PM Linetsky David SVP, Life Sciences Mar 20 '24 Sale 23.66 30 710 7,095 Mar 21 04:11 PM Linetsky David SVP, Life Sciences Mar 19 '24 Sale 23.27 402 9,356 7,125 Mar 20 04:21 PM Linetsky David SVP, Life Sciences Mar 18 '24 Sale 22.22 46 1,022 7,527 Mar 20 04:21 PM Gunzburg Janet Principal Accounting Officer Feb 09 '24 Sale 28.00 480 13,440 39,086 Feb 13 04:58 PM Gunzburg Janet Principal Accounting Officer Feb 02 '24 Sale 27.00 480 12,960 39,566 Feb 06 04:22 PM Gunzburg Janet Principal Accounting Officer Feb 01 '24 Sale 25.99 328 8,525 40,046 Feb 02 06:06 PM Gunzburg Janet Principal Accounting Officer Jan 12 '24 Sale 24.11 205 4,943 40,374 Feb 02 06:06 PM Gandhi Balaji Chief Financial Officer Jan 17 '24 Sale 24.12 9,192 221,726 97,534 Jan 18 04:53 PM Gandhi Balaji Chief Financial Officer Jan 16 '24 Sale 24.55 932 22,876 106,726 Jan 18 04:53 PM VanDuyn Amy Beth SVP, Human Resources Jan 17 '24 Sale 24.12 10,213 246,354 119,695 Jan 18 04:53 PM VanDuyn Amy Beth SVP, Human Resources Jan 16 '24 Sale 24.55 738 18,115 129,908 Jan 18 04:53 PM Davidoff Michael J. SVP, Payer Business Jan 17 '24 Sale 24.12 17,677 426,398 73,391 Jan 18 04:53 PM Davidoff Michael J. SVP, Payer Business Jan 16 '24 Sale 24.55 1,310 32,155 91,068 Jan 18 04:53 PM Linetsky David SVP, Life Sciences Jan 17 '24 Sale 24.12 30,659 739,544 204,059 Jan 18 04:52 PM Linetsky David SVP, Life Sciences Jan 16 '24 Sale 24.55 2,318 56,896 234,718 Jan 18 04:52 PM Hoffman Allison C General Counsel & Secretary Jan 17 '24 Sale 24.12 7,605 183,445 136,859 Jan 18 04:52 PM Hoffman Allison C General Counsel & Secretary Jan 16 '24 Sale 24.55 1,316 32,302 144,464 Jan 18 04:52 PM Roberts Evan Chief Operating Officer Jan 17 '24 Sale 24.12 41,081 990,939 754,532 Jan 18 04:52 PM Roberts Evan Chief Operating Officer Jan 16 '24 Sale 24.55 2,247 55,154 795,613 Jan 18 04:52 PM Indig Chaim Chief Executive Officer Jan 17 '24 Sale 24.12 63,931 1,542,118 1,216,479 Jan 18 04:51 PM Indig Chaim Chief Executive Officer Jan 16 '24 Sale 24.55 3,586 88,020 1,280,410 Jan 18 04:51 PM Gunzburg Janet Principal Accounting Officer Dec 19 '23 Sale 23.72 118 2,799 40,579 Dec 20 04:14 PM Linetsky David SVP, Life Sciences Dec 18 '23 Sale 23.15 234 5,418 7,598 Dec 20 04:13 PM Linetsky David SVP, Life Sciences Dec 19 '23 Sale 23.72 25 593 7,573 Dec 20 04:13 PM Gunzburg Janet Principal Accounting Officer Nov 01 '23 Sale 13.38 298 3,988 40,697 Nov 02 04:39 PM Roberts Evan Chief Operating Officer Oct 31 '23 Option Exercise 2.03 30,000 60,900 775,860 Nov 02 04:36 PM Davidoff Michael J. SVP, Payer Business Oct 16 '23 Sale 16.61 1,198 19,898 92,378 Oct 17 06:22 PM Gandhi Balaji Chief Financial Officer Oct 16 '23 Sale 16.61 861 14,300 85,658 Oct 17 06:19 PM VanDuyn Amy Beth SVP, Human Resources Oct 16 '23 Sale 16.61 665 11,045 118,146 Oct 17 06:17 PM Hoffman Allison C General Counsel & Secretary Oct 16 '23 Sale 16.61 1,297 21,542 115,025 Oct 17 06:15 PM Roberts Evan Chief Operating Officer Oct 16 '23 Sale 16.61 1,971 32,736 745,860 Oct 17 06:14 PM
Index -
P/E 31.16
EPS (ttm) 1.30
Insider Own 0.26%
Shs Outstand 257.84M
Perf Week -0.28%
Market Cap 10.44B
Forward P/E 25.77
EPS next Y 1.57
Insider Trans -10.82%
Shs Float 257.16M
Perf Month 6.31%
Income 327.61M
PEG 1.95
EPS next Q 0.39
Inst Own 67.66%
Short Float 4.25%
Perf Quarter 22.67%
Sales 994.55M
P/S 10.50
EPS this Y 48.41%
Inst Trans 0.26%
Short Ratio 6.51
Perf Half Y 29.74%
Book/sh 14.61
P/B 2.77
EPS next Y 5.92%
ROA 3.59%
Short Interest 10.92M
Perf Year 20.73%
Cash/sh 0.15
P/C 266.90
EPS next 5Y 16.00%
ROE 8.93%
52W Range 27.53 - 41.53
Perf YTD 32.11%
Dividend Est. 2.68 (6.62% )
P/FCF 16.28
EPS past 5Y -6.35%
ROI 3.91%
52W High -2.47%
Beta 0.99
Dividend TTM 2.68 (6.62% )
Quick Ratio -
Sales past 5Y 2.68%
Gross Margin 67.83%
52W Low 47.13%
ATR (14) 0.63
Dividend Ex-Date Aug 05, 2024
Current Ratio -
EPS Y/Y TTM 28.10%
Oper. Margin 55.80%
RSI (14) 63.21
Volatility 1.70% 1.51%
Employees 57
Debt/Eq 1.26
Sales Y/Y TTM 15.93%
Profit Margin 32.94%
Recom 2.56
Target Price 39.29
Option/Short Yes / Yes
LT Debt/Eq 1.26
EPS Q/Q 79.15%
Payout 277.15%
Rel Volume 0.71
Prev Close 40.48
Sales Surprise 2.18%
EPS Surprise 26.65%
Sales Q/Q 2.56%
Earnings Aug 01 AMC
Avg Volume 1.68M
Price 40.51
SMA20 1.60%
SMA50 6.63%
SMA200 23.46%
Trades
Volume 1,059,371
Change 0.06%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-25-24 Downgrade
Mizuho
Outperform → Neutral
$34 → $35
Mar-22-24 Upgrade
Citigroup
Neutral → Buy
$32 → $35
Feb-26-24 Upgrade
Wells Fargo
Equal Weight → Overweight
$31 → $35
Feb-08-24 Upgrade
Exane BNP Paribas
Underperform → Neutral
$30
Jan-30-24 Initiated
Deutsche Bank
Buy
$36
Jan-16-24 Downgrade
BofA Securities
Buy → Neutral
$33 → $31
Nov-06-23 Downgrade
Exane BNP Paribas
Neutral → Underperform
Oct-11-23 Initiated
Exane BNP Paribas
Neutral
$36
Oct-10-23 Upgrade
BofA Securities
Neutral → Buy
$36
Oct-03-23 Initiated
Wedbush
Neutral
$34
Sep-12-23 Initiated
RBC Capital Mkts
Sector Perform
$33
Sep-08-23 Upgrade
Mizuho
Neutral → Buy
$31 → $35
Jul-27-23 Resumed
Berenberg
Buy
$35
Jul-27-23 Initiated
BMO Capital Markets
Market Perform
$34.50
Jul-26-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$32
Apr-20-23 Initiated
Wells Fargo
Overweight
$30
Jan-09-23 Downgrade
Credit Suisse
Neutral → Underperform
$25
Nov-14-22 Downgrade
BofA Securities
Buy → Neutral
$35 → $33
Oct-10-22 Downgrade
Robert W. Baird
Outperform → Neutral
$30
Aug-05-22 Upgrade
BofA Securities
Underperform → Buy
$27 → $35
Show Previous Ratings
Sep-19-24 09:58AM
08:48AM
Sep-07-24 01:28AM
Aug-29-24 10:00AM
Aug-28-24 01:48AM
12:50AM
Loading…
Aug-27-24 12:50AM
Aug-26-24 03:00PM
Aug-13-24 12:00PM
Aug-07-24 02:00PM
Aug-05-24 12:00PM
Aug-03-24 03:30AM
(Thomson Reuters StreetEvents)
Aug-02-24 02:45PM
Aug-01-24 07:30PM
06:35PM
05:32PM
(Associated Press Finance)
04:15PM
Loading…
04:15PM
Jul-31-24 09:15AM
Jul-27-24 11:25PM
Jul-24-24 01:00PM
Jul-03-24 03:03PM
Jul-01-24 11:00AM
Jun-27-24 11:11AM
10:30AM
Jun-25-24 09:55AM
Jun-06-24 12:00PM
Jun-03-24 08:00AM
May-09-24 04:00PM
07:50AM
May-07-24 06:42AM
May-04-24 10:38AM
12:15AM
Loading…
12:15AM
(Thomson Reuters StreetEvents)
May-03-24 05:30PM
03:30PM
04:03AM
May-02-24 06:25PM
05:54PM
05:19PM
(Associated Press Finance)
04:15PM
Apr-18-24 02:31PM
Apr-15-24 12:00PM
Mar-26-24 04:29PM
Mar-25-24 12:00PM
08:39AM
Mar-07-24 08:29AM
Mar-01-24 03:38PM
Feb-27-24 11:17AM
Feb-16-24 11:21AM
08:45AM
Feb-09-24 08:40AM
04:01AM
(Thomson Reuters StreetEvents)
Feb-08-24 04:15PM
Feb-07-24 08:00PM
06:15PM
05:32PM
(Associated Press Finance)
05:00PM
04:20PM
Feb-05-24 09:16AM
Feb-04-24 09:56AM
Feb-01-24 05:10AM
Jan-30-24 10:40PM
Jan-26-24 03:12PM
Jan-11-24 03:24PM
Dec-04-23 08:05AM
Nov-05-23 05:09PM
Nov-04-23 02:56AM
(Thomson Reuters StreetEvents)
Nov-03-23 07:45PM
Nov-02-23 08:30PM
07:17PM
06:33PM
(Associated Press Finance)
04:20PM
Oct-26-23 01:41PM
Oct-20-23 03:00PM
02:20PM
Oct-16-23 06:25PM
Oct-13-23 09:51AM
Oct-04-23 03:53PM
Sep-26-23 05:38PM
Sep-22-23 03:37PM
Sep-21-23 12:00PM
Sep-20-23 12:40PM
Sep-13-23 01:44PM
Sep-07-23 09:40AM
Aug-31-23 11:19AM
Aug-22-23 05:20PM
Aug-16-23 07:00AM
Aug-11-23 11:42AM
Aug-08-23 12:53PM
(American City Business Journals)
Aug-05-23 12:02PM
Aug-03-23 05:30PM
Aug-02-23 09:30PM
07:25PM
06:17PM
04:25PM
Jul-24-23 08:41AM
Jul-20-23 03:30PM
Jul-19-23 09:40AM
Jul-11-23 04:30PM
Jul-10-23 06:17PM
Jul-03-23 08:16AM
Jun-23-23 10:10AM
Omega Healthcare Investors, Inc. engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings. The company was founded on March 31, 1992 and is headquartered in Hunt Valley, MD.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
BOOTH DANIEL J CHIEF OPERATING OFFICER Sep 05 '24 Sale 40.06 25,000 1,001,500 156,725 Sep 06 04:05 PM BOOTH DANIEL J Officer Sep 05 '24 Proposed Sale 40.04 25,000 1,001,000 Sep 05 05:27 PM STEPHENSON ROBERT O CHIEF FINANCIAL OFFICER Aug 26 '24 Sale 38.78 30,000 1,163,520 205,618 Aug 27 04:05 PM Robert Stephenson Officer Aug 26 '24 Proposed Sale 38.75 30,000 1,162,500 Aug 26 04:59 PM BOOTH DANIEL J CHIEF OPERATING OFFICER Aug 23 '24 Sale 38.71 25,000 967,680 181,725 Aug 26 04:05 PM BOOTH DANIEL J Officer Aug 23 '24 Proposed Sale 38.71 25,000 967,682 Aug 23 04:33 PM Egbuonu-Davis Lisa Director Aug 13 '24 Sale 38.00 1,352 51,376 16,766 Aug 13 04:11 PM Lisa Egbuonu-Davis Director Aug 12 '24 Proposed Sale 37.37 2,000 74,740 Aug 12 04:49 PM BOOTH DANIEL J CHIEF OPERATING OFFICER Dec 31 '23 Option Exercise 30.66 22,051 676,084 217,437 Jan 03 12:51 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite